CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study

Phase 3Neutral
AI Analysis

Summary

Newron announced an update on its Phase 3 ENIGMA-TRS 2 study. No specific trial outcomes, data, or timelines were disclosed in this announcement.

Clinical Trial Data

Phase

Phase 3

Importance:5/10
Sentiment:
0.00
Phase 3Clinical TrialENIGMA-TRS 2
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 25, 2026 3:45 PM

Read Original